ESC 2020: DCRI Analysis Sheds New Light on Management of Ischemic Heart Disease and Heart Failure
The ISCHEMIA trial made headlines last year at the American Heart Association 2019 Scientific Sessions, where primary results were presented indicating that invasive heart procedures may not reduce
DCRI Think Tank Outlines Opportunities to Improve Drug Development for Kidney Disease
CARRA Registry Fills Gap in Pediatric Rheumatology
Reliance on Observational Data Could Hinder Discovery of Evidence-Based Treatments
Even in the midst of a global pandemic, taking the time to conduct randomized controlled trials is the most rigorous way to build evidence for potential treatments, according to a recent opinion pi
Combining Randomization with Real-World Data to Move Research Forward
As the proliferation of real-world data continues, it is important to refocus on combining randomized trials with real-world data sources rather than relying on observations or common sense, write
Duke and Local School Districts Partner to Make Data-Driven Decisions on Schooling During COVID-19
DCRI Think Tank Paper Looks to Future of Pragmatic Clinical Trials
Cath Lab Activation Time an Important Quality Metric for Patients with STEMI Presenting in non-PCI Capable Hospitals
Duke Hosts Symposium on Addressing Public Health Crises with Data Science
Challenges to Developing and Implementing Integrated Pain Management Programs
DCRI faculty recently contributed to a paper advocating for a focus on pain management so that progress in combatting the U.S. opioid crisis is not lost in the midst of the COVID-19 pandemic.